05.11.2024
Tuesday
10:00 - 12:15
No cost | Open to wide audience
Bar-Ilan University welcomes 16 students from around the world who are currently studying in the NeuroData – Erasmus Mundus Joint Master's Degree Program in Brain and Data Science. The new students hail from Russia, the United States, the Philippines, Poland, Nigeria, China, Mexico, Spain, Nepal and Ethiopia.
The exhibition showcases paintings, photographs, poems, stories, sculptures, and videos created by academic faculty, administrative staff, and students from the Bar-Ilan community.
From Tarshiha, a village in northern Israel now echoing with the sounds of conflict, emerges a story of resilience and hope. Hanan Abu Hassan's journey reflects not only personal achievement but also the profound impact of unwavering family support combined with institutional belief in promising students.
Bar-Ilan University proudly presents a diverse collection of free online courses (MOOCs), offering world-class education accessible to everyone. Join our distinguished professors on fascinating journeys through various fields of knowledge, all available at your own pace and completely free of charge.
When Russia invaded Ukraine in 2022, Elena Kravtsova, from St. Petersburg, decided it was time to leave her native homeland. The 33-year-old accomplished lawyer gave up her distinguished career to come to Israel. “I lost everything. I came to Israel with nothing and started here from zero because I wanted to live in a free country with democracy,” she says. Kravtsova is now enrolled in the International MBA Program, while also studying cyber security.
When crisis strikes, how do groups of people find their way back to harmony? A fascinating Israeli research study might have found the answer—through the unlikely combination of violins, headphones, and network science.
In a significant step forward for cancer immunotherapy, biotechnology company Pluri has announced a collaboration with Bar-Ilan University to advance MAIT cell therapy for solid tumors. The partnership, supported by the Israel Innovation Authority, brings together cutting-edge cellular technology with innovative genetic engineering to tackle one of medicine's most challenging frontiers: solid tumors.